Abstract LB-141: Increased epigenetic plasticity and tumor heterogeneity predict resistance to CD19 CAR T cell therapy in pre-treatment pediatric acute lymphoblastic leukemia
Katherine E. Masih(National Institutes of Health), Rimas J. Orentas(Capital Caring), Michael C. Kelly(National Cancer Institute), Serifat Adebola(National Cancer Institute), Grégoire Altan‐Bonnet(National Cancer Institute), Ashley Wilson(Center for Infectious Disease Research), Zachary Rae(National Institutes of Health), Abdalla Abdelmaksoud(National Cancer Institute), Justin Lack(Office of Extramural Research), Benjamin Z. Stanton(Nationwide Children's Hospital), David Milewski(National Cancer Institute), Adam Cheuk(National Institutes of Health), Young Song(University of British Columbia), Rebecca Gardner(Seattle Children's Hospital), Jun Wei(Jilin Medical University), Berkley E. Gryder(University School), Xinyu Wen(National Institutes of Health), Chaoyu Wang(Chongqing University), Michael C. Jensen(Seattle Children's Hospital)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k